AlzChem Group AG
XETRA:ACT
AlzChem Group AG
AlzChem Group AG engages in the development, production, and marketing of chemical products. The company is headquartered in Trostberg, Bayern and currently employs 1,636 full-time employees. The Group's operating business is divided into three segments: Specialty Chemicals, Basics & Intermediates and Other & Holding. Its products can be applied in areas, such as nutrition, renewable energy, fine chemicals, agriculture and metallurgy. The firm produces dietary supplements; epoxy resin hardeners for use in adhesives, powder coatings, printed circuit boards and composites; silicon nitride for advanced ceramics and solar wafers; technical gases; specialty fertilizer, germicide for use in pig pens, plant growth regulators and plant protection additives, among others. The company also provides related services. The firm operates production sites in Germany and Sweden, a sales subsidiary in the United States and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.
AlzChem Group AG engages in the development, production, and marketing of chemical products. The company is headquartered in Trostberg, Bayern and currently employs 1,636 full-time employees. The Group's operating business is divided into three segments: Specialty Chemicals, Basics & Intermediates and Other & Holding. Its products can be applied in areas, such as nutrition, renewable energy, fine chemicals, agriculture and metallurgy. The firm produces dietary supplements; epoxy resin hardeners for use in adhesives, powder coatings, printed circuit boards and composites; silicon nitride for advanced ceramics and solar wafers; technical gases; specialty fertilizer, germicide for use in pig pens, plant growth regulators and plant protection additives, among others. The company also provides related services. The firm operates production sites in Germany and Sweden, a sales subsidiary in the United States and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.
Sales Growth: AlzChem reported a 2% increase in group sales for the first nine months of 2025, with Q3 alone up 6.5%, driven mainly by Specialty Chemicals.
Specialty Chemicals Strength: Specialty Chemicals sales rose 9% for the period, and the segment now makes up 66% of group sales, reflecting the company's growth strategy.
Profitability: Group EBITDA was up 12% to EUR 86 million, and the EBITDA margin improved from 18.5% to 20.3%. Net result increased by 20% to EUR 45 million.
Guidance Confirmed: Management reaffirmed full-year sales guidance at around EUR 580 million (lower end of range) and raised expectations for EBITDA to at least EUR 130 million.
CapEx & Expansion: Major investments in new plants and expanded capacity, especially for creatine and nitroguanidine, remain on track and are supported by customer grants.
Creatine Demand & Partnerships: Demand for creatine products is high, with a successful partnership with Ehrmann launching creatine-functional foods, and management is considering further capacity increases.
US Expansion: Site selection for a US nitroguanidine facility is progressing, with detailed P&L analysis underway and discussions including state incentives.
Segment Trends: Basics & Intermediates saw sales decline 8% year-over-year for the period, but showed improvement in Q3 due to a new customer contract.
